These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17381375)

  • 1. Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome.
    Muller MP; Dresser L; Raboud J; McGeer A; Rea E; Richardson SE; Mazzulli T; Loeb M; Louie M;
    Pharmacotherapy; 2007 Apr; 27(4):494-503. PubMed ID: 17381375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada.
    Knowles SR; Phillips EJ; Dresser L; Matukas L
    Clin Infect Dis; 2003 Oct; 37(8):1139-42. PubMed ID: 14523782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse effects of ribavirin and outcome in severe acute respiratory syndrome: experience in two medical centers.
    Chiou HE; Liu CL; Buttrey MJ; Kuo HP; Liu HW; Kuo HT; Lu YT
    Chest; 2005 Jul; 128(1):263-72. PubMed ID: 16002945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.
    Booth CM; Matukas LM; Tomlinson GA; Rachlis AR; Rose DB; Dwosh HA; Walmsley SL; Mazzulli T; Avendano M; Derkach P; Ephtimios IE; Kitai I; Mederski BD; Shadowitz SB; Gold WL; Hawryluck LA; Rea E; Chenkin JS; Cescon DW; Poutanen SM; Detsky AS
    JAMA; 2003 Jun; 289(21):2801-9. PubMed ID: 12734147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The war against an unknown pathogen: rising to the SARS challenge.
    Can Commun Dis Rep; 2003 May; 29(9):77-82. PubMed ID: 12739275
    [No Abstract]   [Full Text] [Related]  

  • 6. A cluster of cases of severe acute respiratory syndrome in Hong Kong.
    Tsang KW; Ho PL; Ooi GC; Yee WK; Wang T; Chan-Yeung M; Lam WK; Seto WH; Yam LY; Cheung TM; Wong PC; Lam B; Ip MS; Chan J; Yuen KY; Lai KN
    N Engl J Med; 2003 May; 348(20):1977-85. PubMed ID: 12671062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials and novel pathogens: lessons learned from SARS.
    Muller MP; McGeer A; Straus SE; Hawryluck L; Gold WL
    Emerg Infect Dis; 2004 Mar; 10(3):389-94. PubMed ID: 15109402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Children hospitalized with severe acute respiratory syndrome-related illness in Toronto.
    Bitnun A; Allen U; Heurter H; King SM; Opavsky MA; Ford-Jones EL; Matlow A; Kitai I; Tellier R; Richardson S; Manson D; Babyn P; Read S;
    Pediatrics; 2003 Oct; 112(4):e261. PubMed ID: 14523209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current concepts in SARS treatment.
    Fujii T; Nakamura T; Iwamoto A
    J Infect Chemother; 2004 Feb; 10(1):1-7. PubMed ID: 14991510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003.
    Leong HN; Ang B; Earnest A; Teoh C; Xu W; Leo YS
    Trop Med Int Health; 2004 Aug; 9(8):923-7. PubMed ID: 15303999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common adverse events associated with ribavirin therapy for Severe Fever with Thrombocytopenia Syndrome.
    Lu QB; Zhang SY; Cui N; Hu JG; Fan YD; Guo CT; Qin SL; Yang ZD; Wang LY; Wang HY; Zhang XA; Liu W; Cao WC
    Antiviral Res; 2015 Jul; 119():19-22. PubMed ID: 25892251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children.
    Gavin PJ; Katz BZ
    Pediatrics; 2002 Jul; 110(1 Pt 1):e9. PubMed ID: 12093990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of corticosteroids in SARS.
    Oba Y
    N Engl J Med; 2003 May; 348(20):2034-5; author reply 2034-5. PubMed ID: 12748321
    [No Abstract]   [Full Text] [Related]  

  • 14. High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome.
    Ho JC; Ooi GC; Mok TY; Chan JW; Hung I; Lam B; Wong PC; Li PC; Ho PL; Lam WK; Ng CK; Ip MS; Lai KN; Chan-Yeung M; Tsang KW
    Am J Respir Crit Care Med; 2003 Dec; 168(12):1449-56. PubMed ID: 12947028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial.
    Liu CH; Liu CJ; Huang CF; Lin JW; Dai CY; Liang CC; Huang JF; Hung PH; Tsai HB; Tsai MK; Lee CY; Chen SI; Yang SS; Su TH; Yang HC; Chen PJ; Chen DS; Chuang WL; Yu ML; Kao JH
    Gut; 2015 Feb; 64(2):303-11. PubMed ID: 24747867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of ribavirin and corticosteroids for severe acute respiratory syndrome.
    Lau EH; Cowling BJ; Muller MP; Ho LM; Tsang T; Lo SV; Louie M; Leung GM
    Am J Med; 2009 Dec; 122(12):1150.e11-21. PubMed ID: 19958895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of combination interferon alfa-2b/ribavirin therapy in chronic hepatitis C-relapsed and treatment-naive patients.
    Maddrey WC
    Semin Liver Dis; 1999; 19 Suppl 1():67-75. PubMed ID: 10349694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population mortality during the outbreak of Severe Acute Respiratory Syndrome in Toronto.
    Hwang SW; Cheung AM; Moineddin R; Bell CM
    BMC Public Health; 2007 May; 7():93. PubMed ID: 17535440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic treatment of SARS: current knowledge and recommendations.
    Tai DY
    Ann Acad Med Singap; 2007 Jun; 36(6):438-43. PubMed ID: 17597972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse events associated with ribavirin in sofosbuvir-based therapies for patients with chronic hepatitis C: A community practice experience.
    Tong MJ; Chang PW; Huynh TT; Rosinski AA; Tong LT
    J Dig Dis; 2016 Feb; 17(2):113-21. PubMed ID: 26749171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.